LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 1 | 47.93 | 27.76 | 760 | 4421 | 0.1719 | 0.5721 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 49.63 | 27.76 | 60 | 4818 | 0.0125 | 0.1092 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 49.63 | 27.76 | 674 | 4818 | 0.1399 | 0.5354 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 49.63 | 27.76 | 1 | 4818 | 0.0002 | -0.3603 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 49.63 | 27.76 | 769 | 4818 | 0.1596 | 0.5628 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 51.33 | 27.76 | 68 | 5117 | 0.0133 | 0.1264 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 51.33 | 27.76 | 682 | 5117 | 0.1333 | 0.5302 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 51.33 | 27.76 | 1 | 5117 | 0.0002 | -0.3570 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 51.33 | 27.76 | 782 | 5117 | 0.1528 | 0.5582 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 53.04 | 27.76 | 68 | 5365 | 0.0127 | 0.1252 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 53.04 | 27.76 | 667 | 5365 | 0.1243 | 0.5199 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 53.04 | 27.76 | 1 | 5365 | 0.0002 | -0.3544 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 53.04 | 27.76 | 742 | 5365 | 0.1383 | 0.5413 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 54.74 | 27.76 | 71 | 5606 | 0.0127 | 0.1305 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 54.74 | 27.76 | 688 | 5606 | 0.1227 | 0.5207 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 54.74 | 27.76 | 1 | 5606 | 0.0002 | -0.3521 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 54.74 | 27.76 | 732 | 5606 | 0.1306 | 0.5331 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 56.45 | 27.76 | 79 | 5745 | 0.0138 | 0.1456 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 56.45 | 27.76 | 741 | 5745 | 0.1290 | 0.5325 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 56.45 | 27.76 | 1 | 5745 | 0.0002 | -0.3508 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 56.45 | 27.76 | 735 | 5745 | 0.1279 | 0.5309 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 58.15 | 27.76 | 83 | 5906 | 0.0141 | 0.1522 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 58.15 | 27.76 | 759 | 5906 | 0.1285 | 0.5339 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 58.15 | 27.76 | 1 | 5906 | 0.0002 | -0.3493 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 58.15 | 27.76 | 701 | 5906 | 0.1187 | 0.5182 | MN20160318_Q01 | H08 |